Anivive Secures $20 Million Investment from Leonid Capital Partners to Develop the…
Funding expands manufacturing readiness for Valley fever vaccineThis follows Anivive's $33MM NIAID contract for…
PR Newswire is a distributor of press releases headquartered in New York City.